ALPIONER Therapeutics
Company

ALPIONER Therapeutics

Biotechnology Research Grenoble, Isère, Fr 2 employees
Employees
2
Contacts
1
Emails
1

ALPIONER Therapeutics Overview

Headquarters
Grenoble, Isère, Fr
Industry
Biotechnology Research
Employees
2
Founded
2023
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About ALPIONER Therapeutics

ALPIONER Therapeutics is a biotech company developing new generation of immunotherapies against cancer and multi-resistant pathogens. Its aT3-plaform is leveraging a bacterial secretion system to inject high quantity of peptides or functional proteins, into the cytosol of the host cell. ALP-102 is a first-in-class vaccine candidate targeting Pa infections while ALP-201-neo is neoantigen-based personnalized cancer vaccine.

ALPIONER Therapeutics Contact Details

People in AeroLeads
1
With contact data
1
Email contacts
1
100.0% coverage

ALPIONER Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Frederic Fasano Pharma Executive - Pharma - Biotech
Email

Compare Similar Companies to ALPIONER Therapeutics